Calithera Biosciences, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | 0.00% | -20.32% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 97.45K | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CALA Stock
- News Calithera Biosciences, Inc.
- Calithera Biosciences, Inc. Auditor Raises 'Going Concern' Doubt